APYX vs DAL · rev $48.1M vs P/E 12, rev $61.64B
Apyx Medical Inc (APYX) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
APYX currently screens at market cap $179.6M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the APYX and DAL stock pages for the full models.
Not investment advice.